Axonis Therapeutics Funding: $157M Raised, Series A (2024)

Axonis Therapeutics is a Biotech company based in Boston. It has raised $157M in total funding. Latest round: Series A.

Axonis Therapeutics funding overview

Axonis Therapeutics is a Biotech company based in Boston. Axonis Therapeutics has raised $157M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Axonis Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures and 7 others. 13 distinct backers are named across the disclosed rounds.

Axonis Therapeutics at a glance

Total raised
$157M
Latest round
Series A
Latest round date
October 2024
Industry
Biotech
Headquarters
Boston
Notable investors
Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures, Lumira Ventures, Alexandria Venture Investments

Frequently asked about Axonis Therapeutics funding

How much has Axonis Therapeutics raised?
Axonis Therapeutics has raised $157M in total disclosed funding across the rounds on record.
Who has invested in Axonis Therapeutics?
Cormorant Asset Management, venBio Partners, Sofinnova Investments, MRL Ventures Fund, Perceptive Advisors, Solasta Ventures are named among the investors backing Axonis Therapeutics.
What was the latest Axonis Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is Axonis Therapeutics based?
Axonis Therapeutics is based in Boston.
What sector does Axonis Therapeutics operate in?
Axonis Therapeutics is tracked under Biotech from Boston, with $157M in disclosed funding.
When did Axonis Therapeutics last raise?
The last disclosed Axonis Therapeutics round closed in October 2024 at Series A.

We update the Axonis Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Boston and their backers are listed below.

Axonis Therapeutics founders (1)

Companies related to Axonis Therapeutics (40)

Browse related funding lists (10)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades